Milan Kovacevic
Plus aucun poste en cours
Profil
Milan Kovacevic worked as a Senior Medical Director & Medical Director at Synvista Therapeutics, Inc., a Medical Officer-Global Safety & Project Manager at Kendle International LLC, a Vice President-Clinical Operations at GenVec, Inc., and a Clinical Research Scientist at Cangene Corp.
He graduated from the University of Belgrade with a graduate degree and an MBA.
Anciens postes connus de Milan Kovacevic
| Sociétés | Poste | Fin |
|---|---|---|
| GENVEC INC | Directeur Technique/Scientifique/R&D | - |
Kendle International LLC
 Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
| CANGENE CORPORATION | Directeur Technique/Scientifique/R&D | - |
| SYNVISTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Milan Kovacevic
| University of Belgrade | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNVISTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
